Invivyd (IVVD) Long-Term Deferred Tax (2023 - 2025)
Invivyd (IVVD) posted Long-Term Deferred Tax of $719000.0 for Q4 2025, down 99.71% on a QoQ basis from $244.9 million in Q4 2024, and down 99.71% year-over-year from $244.9 million in Q4 2024.
Invivyd (IVVD) Long-Term Deferred Tax (2023 - 2025) Analysis & Trends
Invivyd's Long-Term Deferred Tax history runs 3 years deep, the most recent figure standing at $719000.0 for Q4 2025.
- Quarterly Long-Term Deferred Tax fell 99.71% year-over-year to $719000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $719000.0 (down 99.71% YoY) and the FY2025 annual result came in at $719000.0, down 99.71% from the prior year.
- Long-Term Deferred Tax was $719000.0 for Q4 2025 at Invivyd, down from $244.9 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $244.9 million in Q4 2024 and bottomed at $719000.0 in Q4 2025.
- A 3-year average of $148.9 million and a median of $201.1 million in 2023 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2024 — Long-Term Deferred Tax gained 21.81% — and 2025, when it plunged 99.71%.
- Invivyd's Long-Term Deferred Tax stood at $201.1 million in 2023, then climbed by 21.81% to $244.9 million in 2024, then plunged by 99.71% to $719000.0 in 2025.
- Business Quant data shows IVVD's Long-Term Deferred Tax at $719000.0 in Q4 2025, $244.9 million in Q4 2024, and $201.1 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Invivyd | 104.07 Mn | -122.62 Mn | 16.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 719,000.00 |
| Dec 31, 2024 | 244.95 Mn |
| Dec 31, 2023 | 201.08 Mn |